NDC product
Theralast Clinical Strength MD3 Topical Analgesic
NDC 80967-002 · SKIN SHERPA NORTH AMERICA LLC
Key facts
| Product NDC | 80967-002 |
|---|---|
| Proprietary name | Theralast Clinical Strength MD3 Topical Analgesic |
| Labeler | SKIN SHERPA NORTH AMERICA LLC |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Application number | part348 |
| Marketing start | Nov 15, 2020 |
| Listing certified through | Dec 31, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: